| IPI00106783 - HSD3B7, 3 BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 7. | |
|---|---|
| Uniprot Accession: Q9H2F3 | |
| Uniprot ID: 3BHS7_HUMAN | |
| Mapping: Chr 16, 30904029 - 30907972 | |
| Entrez Gene: 80270 | |
| Entrez MapView: |
|
| +All IPI Database Cross References | |
| IPI records in this ortholog cluster (Cluster: MGI_ORTHOLOGY_1234) |
|---|
| Rat: Hsd3b7, 3 BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 7. |
| Mouse: Hsd3b7, 3 BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 7. |
| Mouse: Hsd3b7, ISOMERASE 7 ISOFORM B. |
| Mouse: Hsd3b7, 11 KDA PROTEIN. |
| Mouse: Hsd3b7, 9 KDA PROTEIN. |
| Mouse: Hsd3b7, 38 KDA PROTEIN. |
| Mouse: Hsd3b7, HSD3B7 PROTEIN. |
| Human: HSD3B7, NORVEGICUS CCA2 MRNA. |
| Human: HSD3B7, 3 BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 7. |
| GO Term | Aspect | Human | Mouse | Rat |
|---|---|---|---|---|
| integral to membrane | C | IEA | IEA | IEA |
| cellular_component | C | ND | ||
| endoplasmic reticulum | C | IEA | IEA | IEA |
| microsome | C | IDA | ||
| membrane | C | IEA | IEA | IEA |
| steroid delta-isomerase activity | F | IEA | IEA | IEA |
| cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity | F | IDA | ||
| 3-beta-hydroxy-delta5-steroid dehydrogenase activity | F | IEA NAS | IEA | IEA |
| isomerase activity | F | IEA | ||
| oxidoreductase activity | F | IEA | IEA | IEA |
| C21-steroid hormone biosynthetic process | P | IEA | IEA | IEA |
| bile acid metabolic process | P | TAS | ||
| bile acid biosynthetic process | P | TAS | ||
| steroid biosynthetic process | P | IEA | IEA | |
| regulation of cell growth | P | IDA |
| GO Graph Color Key: | Rat | Mouse | Human | Rat & Mouse | Mouse & Human | Rat & Human | Rat, Mouse & Human |
SVG image
| GO Graph Color Key: | Rat | Mouse | Human | Rat & Mouse | Mouse & Human | Rat & Human | Rat, Mouse & Human |
SVG image
| GO Graph Color Key: | Rat | Mouse | Human | Rat & Mouse | Mouse & Human | Rat & Human | Rat, Mouse & Human |
SVG image
| MP Term | Aspect | Human | Mouse | Rat |
|---|---|---|---|---|
| skin/coat/nails phenotype | MP | Un | ||
| cellular phenotype | MP | Un | ||
| homeostasis/metabolism phenotype | MP | Un | ||
| lethality-postnatal | MP | Un | ||
| digestive/alimentary phenotype | MP | Un | ||
| growth/size phenotype | MP | Un |
| DO Term | Aspect | Human | Mouse | Rat |
|---|---|---|---|---|
| Cholestasis, Intrahepatic | D | ISS |
| KEGG Pathway | Human | Mouse | Rat |
|---|---|---|---|
| Glycine, serine and threonine metabolism (00260) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| Fructose and mannose metabolism (00051) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| Bisphenol A degradation (00363) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| Lysine degradation (00310) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| Galactose metabolism (00052) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| Tetrachloroethene degradation (00625) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| Linoleic acid metabolism (00591) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| Bile acid biosynthesis (00120) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| Butanoate metabolism (00650) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |